Home » FDA Approves Baxter's Rixubis for Hemophilia B
FDA Approves Baxter's Rixubis for Hemophilia B
The FDA approved Baxter’s Rixubis, the first new drug for Hemophilia B in 15 years.
Pharma Times
Pharma Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May